You are here: start ยป treatment_sodium_bicarbonate

Sodium Bicarbonate (Treatment)

This is an old revision of the document!


Sodium Bicarbonate (Treatment)

1. Overview

Sodium Bicarbonate (NaHCO3) is the primary antidote for TCA poisoning. As these are, by far, the most common cause of cardiac arrest in out of hospital poisonings - patients with drug overdose presenting in cardiac arrest or arresting shortly after arrival should receive a bolus of 1 ampoule of NaHCO3.

The patient should then be hyperventilated.

2. Toxicologic Indications & Dosing

2.1 QRS Widening Secondary to Fast Sodium Channel Blockade

  • Also see: Tricyclic antidepressants, bupropion, propranolol, flecainide, local anesthetic agents.
  • Adult:
    • ๐Ÿ’Š Sodium Bicarbonate 1-2 mmol/kg IV (i.e. 1-2 mL/kg of 8.4% NaHCO3), q2min.
  • Child:
    • ๐Ÿ’Š๐Ÿ‘ถ Sodium Bicarbonate 1-2 mmol/kg IV (i.e. 1-2 mL/kg of 8.4% NaHCO3), q2min.
  • Repeat boluses until signs of cardiotoxicity (QRS widening, wide complex dysrhythmias) improve.
  • Do not exceed serum pH 7.55.

2.2 Salicylate Toxicity

  • Also see: Salicylate toxicity.
  • Alkalinization therapy in salicylate toxicity works by โ†“ CNS redistribution of salicylates (alters drug distribution), and enhances urinary elimination (ion trapping).
  • Adult:
    • ๐Ÿ’Š Sodium Bicarbonate 1-2 mmol/kg IV (i.e. 1-2 mL/kg of 8.4% NaHCO3), as initial dose, then start infusion.
    • ๐Ÿ’Š Sodium Bicarbonate 25 mmol/hr IV infusion.
      • e.g. 150 mmol of Sodium Bicarbonate in 850 mL 5% dextrose, at 250 mL/hr.
  • Child:
    • ๐Ÿ’Š๐Ÿ‘ถ Sodium Bicarbonate 1-2 mmol/kg IV (i.e. 1-2 mL/kg of 8.4% NaHCO3), as initial dose, then start infusion.
    • ๐Ÿ’Š๐Ÿ‘ถ Sodium Bicarbonate 1.5-2ร— patient's hourly maintenance fluid requirement (weight-based) IV infusion, then titrate to goal pH.
  • Maintain normokalemia.
  • Goals:
    • Serum pH 7.5-7.55.
    • Urinary pH >7.5.
    • Urine output 2-3 mL/kg/hr.

2.3 Indication 3

  • Also see: relevant pages.
  • Adult: ๐Ÿ’Š DrugName Dose Route, Frequency.
  • Child: ๐Ÿ’Š๐Ÿ‘ถ DrugName Dose Route, Frequency.
  • Other notes if applicable.

3. Cautions & Contraindications

  • Metabolic or respiratory alkalosis
  • Severe hypernatremia
  • Hypokalemia
  • Acute pulmonary edema

4. Special Populations

Pregnancy rating:

Lactation:

Renal impairment:

Hepatic impairment:

5. Adverse Effects

  • Description of important/serious adverse effects, e.g.
  • Serotonin syndrome:
  • Systems e.g.
  • GI:
  • Resp:
  • MSK: local phlebitis
  • Frequency e.g.
  • Common:

6. Pharmacology

6.1 Pharmacodynamics

Mechanism of action:

6.2 Pharmacokinetics

Absorption:

  • Oral bioavailability:
  • GI tract absorption:
  • First pass metabolism:

Distribution:

  • Vd:
  • Lipid solubility:
    • Crosses/Does not cross BBB
    • Crosses/Does not cross placenta
    • Excreted/Not excreted in breast milk
  • Protein binding:
  • Tmax:

Metabolism:

Excretion:

  • Elimination tยฝ:
  • Hepatic clearance:
  • Renal clearance:

6.3 Pharmaceutics

Formulation:

7. References

Useful general references:

treatment_sodium_bicarbonate.1744520676.txt.gz ยท Last modified: 2025/04/13 01:04